Insider sales are negligible in size and carry no material signal. Monitor for greater-than-0.1% of market cap sales by C-suite executives before drawing bearish conclusions.
Price Chart
Executive Summary
Three insiders at Metagenomi Therapeutics (MGX) sold a total of $9K in open-market shares on June 5, 2026, representing ~0.02% of the $46M market cap. These sales are trivially small and likely routine diversification or tax-related moves. A director also received a non-cash grant of 21,000 shares, which carries no economic signal.
Key Financial Metrics
Key Facts
- Three insiders sold open-market shares totaling ~$9K on June 5, 2026
- Sales represent ~0.02% of MGX's $46M market cap
- CFO Pamela Wapnick sold $3.7K; Jian Irish sold $4.9K; Matthew Wein sold $725
- Director Juergen Eckhardt received 21,000 shares as a grant (non-cash) on June 9, 2026
Financial Impact
Total insider sales of approximately $9,300, which is immaterial relative to market cap
Risk Factors
- No material risk identified from this filing; the low trading volume could amplify any small sell order's price impact in a thin stock
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MGX-1781199563582 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | 8-K | $1.14 $0.8310 | ▼ −27.11% | ▼ −26.55% | $0.8200 (−28.07%) |
Aug 10, 2026 11w ago | 8-K | $1.21 $1.15 | ▲ +4.96% | ▲ +3.90% | $0.8200 (+32.23%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.23 $1.26 | ▲ +2.44% | ▼ −1.18% | $0.8200 (−33.33%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.23 $1.26 | ▲ +2.44% | ▼ −1.18% | $0.8200 (−33.33%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.23 $1.26 | ▲ +2.44% | ▼ −1.18% | $0.8200 (−33.33%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.23 $1.26 | ▲ +2.44% | ▼ −1.18% | $0.8200 (−33.33%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.23 $1.26 | ▲ +2.44% | ▼ −1.18% | $0.8200 (−33.33%) |
May 11, 2026 24w ago | 8-K | $1.35 $1.23 | ▼ −8.89% | ▼ −7.16% | $0.8200 (−39.26%) |
May 11, 2026 24w ago | Press Release | $1.35 $1.23 | ▲ +8.89% | ▲ +7.16% | $0.8200 (+39.26%) |
Apr 27, 2026 26w ago | DEFA14A | $1.44 $1.36 | ▼ −5.56% | ▼ −11.02% | $0.8200 (−43.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers